compound version of tirzepatide Compounded With B6 (Pyridoxine) Compounded Tirzepatide for Weight Loss

Description

Occasionally, authors may express opinions that represent their own viewpoint

The VA covers GLP-1s mainly for diabetes, with weight-loss access requiring documented medical necessity

doi: 10.3389/fphar.2024.1370411 Received 14 January 2024 Accepted 06 May 2024 Published 27 May 2024 Volume 15 - 2024 Edited by Petra Scholze, Medical University of Vienna, Austria Reviewed by Ryuta Kinno, Showa University Northern Yokohama Hospital, Japan Waqar Waheed, University of Vermont, United States Updates Copyright 2024 Ma, Liu, Wang, Yang and Zhu

Currently, the only version of semaglutide licenced to treat weight loss is Wegovy, which is administered as a once-weekly injection

This insight helps your provider predict whether you'll be a fast responder, average responder, or someone who benefits more from dual-compound therapy like GLP-Squared